Ofatumumab, a fully human anti-CD20 monoclonal antibody, is a disease-modifying therapy (DMT) approved for the treatment of ...

The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...

Press Release The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million investment in its Halo Pharma ...

"The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

The initial container systems will include 0.5 mL, 1 mL long, and 1 mL short syringes, along with 2R vials ... and liquid formulations for the past 20 years, will undergo significant renovations ...

Auxiliary nurse Feyisayo Ogedengbe, who administered a tetanus injection to late singer Ilerioluwa 'Mohbad' Aloba, has narrated how he died. On 6 October 2023, PREMIUM TIMES reported that the police ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Shah and colleagues take advantage of the presence of maternal and somatic ribosomes in zebrafish and confirm their differential expression during development. The authors convincingly show that ...

The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...

Is it Botox, fillers or a new facelift? While many celebrities are looking 20 years younger, everyone is wondering what they ...

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's") and Alvotech (NASDAQ: ALVO), a global biotech ...

Q4 2024 Earnings Call Transcript March 12, 2025 Operator: Greetings. And welcome to the KORU Medical Systems’ Fourth Quarter ...